199 completed, 52 terminated, 19 active not recruiting, 18 recruiting. 164 Phase 2, 68 Phase 1, 46 Phase 4, 44 Phase 3, 19 Not applicable.
Follow Cellcept: new trials by email Literature Review of Cellcept trials Research Report on Cellcept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant Biospecimen Collection, Busulfan, Computed Tomography - Acute Myeloid Leukemia, Graft Versus Host Disease | Phase 1 | Recruiting | City of Hope Medical Center | 15 | 2026-06-12 | 2026-07-01 |
| Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial Allogeneic Hematopoietic Stem Cell Transplantation, Axatilimab, Biospecimen Collection - Hematopoietic and Lymphatic System Neoplasm | Phase 2 | Withdrawn | Mayo Clinic | 2026-06-01 | 2026-09-03 | |
| Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation Allogeneic Hematopoietic Stem Cell Transplantation, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia | Phase 1 | Recruiting | OHSU Knight Cancer Institute | 40 | 2026-04-21 | 2026-10-05 |
| Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies Fludarabine, Intermediate-dose Total Body Irradiation (TBI), Post-transplant Cyclophosphamide (PTCy) - Allogeneic Stem Cell Transplant Recipient | Phase 2 | Recruiting | Hackensack Meridian Health | 209 | 2026-01-06 | 2026-03-23 |
| Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty Methotrexate, Sulfasalazine, Hydroxychloroquine - Rheumatic Disease | Phase 2 | Recruiting | NYU Langone Health | 80 | 2025-12-12 | 2026-07-09 |
| Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Aplastic Anemia | Phase 2 | Active not recruiting | Fred Hutchinson Cancer Center | 1 | 2025-09-25 | 2026-05-22 |
| Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial. Mycophenolate Mofetil (MMF) Maintenance Group, Mycophenolate Mofetil (MMF) Withdrawal Group - Kidney Transplantation, Mycophenolate Mofetil | Phase 4 | Recruiting | Mayo Clinic | 350 | 2025-06-13 | 2026-03-20 |
| Belatacept in Heart Transplantation Belatacept, Tacrolimus, Mycophenolate Mofetil/Sodium - Heart Transplant | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 66 | 2025-01-29 | 2026-10-09 |
| A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies Ossium HPC Marrow, Bone Marrow Transplant, Pre-transplant conditioning - Myeloablative (MAC), Pre-transplant conditioning - Reduced Intensity (RIC) - Acute Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Active not recruiting | Ossium Health, Inc. | 12 | 2024-08-16 | 2026-09-10 |
| Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases Biospecimen Collection, Bone Marrow Aspirate, Cyclophosphamide - Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Fred Hutchinson Cancer Center | 54 | 2024-07-23 | 2026-10-26 |
| Advancing Transplantation Outcomes in Children Sirolimus, Belatacept, Mycophenolate Mofetil - Kidney Transplant | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 200 | 2024-05-22 | 2026-10-23 |
| Early Use of Long-acting Tacrolimus in Lung Transplant Recipients Tacrolimus Extended Release Oral Tablet [Envarsus], Tacrolimus, Mycophenolate Mofetil Hydrochloride - Lung Transplant; Complications | Early Phase 1 | Recruiting | Vanderbilt University Medical Center | 48 | 2023-12-01 | 2026-05-15 |
| Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency Mycophenolate Mofetil, Tacrolimus, Post-Transplant Cyclophosphamide - GATA2, Immunodeficiency | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 13 | 2023-11-29 | 2026-08-11 |
| De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil - Graft-versus-host Disease | Phase 2 | Active not recruiting | Medical College of Wisconsin | 56 | 2023-08-29 | 2026-03-12 |
| Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome Biospecimen Collection, Bone Marrow Aspiration, Busulfan - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 3 | Active not recruiting | Children's Oncology Group | 66 | 2023-03-15 | 2026-07-30 |
| Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) Mycophenolate Mofetil, Allopurinol, Irinotecan - Small-cell Lung Cancer, Small Cell Lung Carcinoma | Phase 1 | Terminated | Washington University School of Medicine | 17 | 2023-02-27 | 2024-12-05 |
| SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease Dapagliflozin 10mg Tab, Standard maintenance therapy - Lupus Nephritis, Chronic Kidney Diseases | Phase 2 | Recruiting | The University of Hong Kong | 150 | 2023-01-04 | 2024-12-16 |
| Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus Mycophenolate Mofetil, Placebo for Mycophenolate Mofetil, Voclosporin - Systemic Lupus Erythematosus | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 12 | 2022-11-30 | 2025-09-09 |
| Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma Mycophenolate Mofetil, Quality-of-Life Assessment, Radiation Therapy - Astrocytoma, Glioblastoma | Phase 1 | Active not recruiting | Northwestern University | 86 | 2022-08-08 | 2026-08-26 |
| Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection - Neuroblastoma | Phase 2 | Not yet recruiting | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 64 | 2022-08-01 | 2022-07-01 |
Showing 20 of 325. Sign in to see all of them.
Leukemia, Myeloid, Acute (78) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (64) · Lymphoma, Non-Hodgkin (59) · Hodgkin Disease (58) · Leukemia, Lymphocytic, Chronic, B-Cell (58) · Multiple Myeloma (50) · Myelodysplastic Syndromes (47) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (36) · Lymphoma, Mantle-Cell (33) · Myeloproliferative Disorders (33) · Lymphoma, Large B-Cell, Diffuse (32) · Leukemia, Myelomonocytic, Chronic (30) · Lymphoma, Follicular (29) · Lymphoma, B-Cell, Marginal Zone (27) · Waldenstrom Macroglobulinemia (27)
Fred Hutchinson Cancer Center (66) · M.D. Anderson Cancer Center (20) · Hoffmann-La Roche (19) · National Institute of Allergy and Infectious Diseases (NIAID) (12) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (12) · Astellas Pharma Inc (10) · Stanford University (10) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (7) · City of Hope Medical Center (5) · Mayo Clinic (5) · University of Nebraska (5) · Washington University School of Medicine (5) · Case Comprehensive Cancer Center (4) · Dr. Reddy's Laboratories Limited (4) · Roxane Laboratories (4)
United States (241) · Germany (25) · Canada (21) · Italy (21) · China (10) · Spain (10) · France (9) · Australia (8) · Czechia (8) · Denmark (7) · India (7) · United Kingdom (7) · South Korea (6) · Belgium (5) · Hungary (5)
Brenda Sandmaier (18) · David Maloney (7) · Dolores Grosso, DNP, CRNP (5) · Neal Flomenberg, MD (5) · Usama Gergis, MD (5) · George Georges (4) · Rachel B. Salit (4) · Robert Lowsky (4) · Johnnie Orozco (3) · Marco Mielcarek (3) · Ajay Gopal (2) · Amy E DeZern, MD (2) · Ann Woolfrey (2)
PMID 32499241, PMID 39382091, PMID 11919310, PMID 12176626, PMID 12176628, PMID 12359731, PMID 15049798, PMID 15233820, PMID 15692967, PMID 16192477, PMID 16382014, PMID 16407509, PMID 16468960, PMID 16687625, PMID 16790698, PMID 17452226, PMID 17469162, PMID 17485423, PMID 17717203, PMID 17901414, PMID 18035553, PMID 18424759, PMID 18431244, PMID 18497677, PMID 18554762, PMID 18557726, PMID 18641099, PMID 18698002, PMID 18946341, PMID 19005182, PMID 19066739, PMID 19270260, PMID 19307792, PMID 19423725, PMID 19494809, PMID 19714613, PMID 19776222, PMID 19786617, PMID 19892673, PMID 19900571, PMID 19926370, PMID 19933596, PMID 20039429, PMID 20124953, PMID 20148887, PMID 20236866, PMID 20498245, PMID 20528878, PMID 20600032, PMID 20670958
P30CA015704 (49), P01CA018029 (15), P01CA078902 (12), P01CA044991 (5), P30CA036727 (3), 2009 (2), P01CA015396 (2), P01CA049605 (2), P01CA148600 (2), P01HL036444 (2), P01HL122173 (2), P30CA016672 (2), P30CA033572 (2), P30CA043703 (2), RC2HL101844 (2)